Thu, Oct 17 4:21am


DRNA $14.99 0.01 (0.07%)
Dicerna Pharmaceuticals Inc
NASDAQ: DRNA $1,020 Million Small-Cap. Biotech & Pharma industry. 5 Year Return 58%. 1 Year Return 15%. 2019 YTD Return 27%. Earnings in 18 days on Mon, Nov 4. (Use the Earnings tab below to add this date to your calendar.)

DRNA Profile

Market Cap 1 Billion
DRNA Description

Dicerna Pharmaceuticals Inc is a biotechnology company involved in the discovery and development of innovative treatments for rare inherited diseases affecting the liver, along with cancers, and other therapeutic areas to address liver problems. The company is using ribonucleic acid interference (RNA) technology platform to develop its products. The product candidates are DCR-PHXC (for primary hyperoxaluria), DCR-undisclosed (for orphan genetic disease), DCR-PCSK9 (for cardiovascular disease), and DCR-HBV (for hepatitis B virus) among others.

Visit Website

DRNA Earnings

EPS -0.35 P/E Ratio 0.00
Previous Thu, Aug 8, 2019
Latest Mon, Nov 4, 2019 (In 18 days)

DRNA Dividend

Yield --
Ex-Date --
Pay Date --
History --

DRNA Charts

1 Year
Dec 24, 2018
Jun 18, 2019

Symbol Price Day Ξ” YTD Ξ”
DRNA $14.99 -0.07% 27.36%


Symbol Surfing

How can we make Symbol Surfing better?

©2019 Symbol Surfing All Rights Reserved.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Cookies Policy | Terms Of Service | Privacy Policy